ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1317.xmlActivity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1317.pdf2026-04-18Activity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1310.xmlExceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1310.pdf2026-04-18Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1305.xmlTime to Change: Supporting Sexual and Gender Minority People—An Underserved, Understudied Cancer Risk Population2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1305.pdf2026-04-18Time to Change: Supporting Sexual and Gender Minority People—An Underserved, Understudied Cancer Risk Populationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1297.xmlSexual Health Is Paramount in the Counseling of Women at Risk for Breast or Ovarian Cancer Undergoing Risk-Reducing Surgery2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1297.pdf2026-04-18Sexual Health Is Paramount in the Counseling of Women at Risk for Breast or Ovarian Cancer Undergoing Risk-Reducing Surgeryhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1295.xmlLetter to the Editor: Defining “Standard of Care”2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1295.pdf2026-04-18Letter to the Editor: Defining “Standard of Care”https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-pxxv.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-pxxv.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1289.xmlWho's Watching the Kids?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1289.pdf2026-04-18Who's Watching the Kids?https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-pxli.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-pxli.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1392.xmlApoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trial2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1392.pdf2026-04-18Apoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trialhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1383.xmlAddition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1383.pdf2026-04-18Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1331.xmlNCCN Guidelines Insights: Central Nervous System Cancers, Version 1.20172026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1331.pdf2026-04-18NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1351.xmlNonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1351.pdf2026-04-18Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1363.xmlDo Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1363.pdf2026-04-18Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1379.xmlSexual and Gender Minority Issues Across NCCN Guidelines: Results From a National Survey2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1379.pdf2026-04-18Sexual and Gender Minority Issues Across NCCN Guidelines: Results From a National Surveyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1429.xmlEmerging Role of CAR T Cells in Non-Hodgkin's Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1429.pdf2026-04-18Emerging Role of CAR T Cells in Non-Hodgkin's Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1439.xmlTruth in Advertising: Do Clinical Trial Publications Tell It All?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1439.pdf2026-04-18Truth in Advertising: Do Clinical Trial Publications Tell It All?https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1414.xmlHairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1414.pdf2026-04-18Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1401.xmlHealthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/11/article-p1401.pdf2026-04-18Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer